rethinkPeptides Search
Menu
Home / Research library
Study breakdown

BPC-157 Heals Stomach Damage Caused by Complete Dopamine System Shutdown

RPEP-006202000Sikiric, P; Separovic, J; Buljat, G; Anic, T; Stancic-Rokotov, D; Mikus, D; Duplancic, B; Marovic, A; Zoricic, I; Prkacin, I; Lovric-Bencic, M; Aralica, G; Ziger, T; Perovic, D; Jelovac, N; Dodig, G; Rotkvic, I; Mise, S; Seiwerth, S; Turkovic, B; Grabarevic, Z; Petek, M; Rucman, R
Animal StudyPreliminary evidence
The takeaway

When both dopamine receptor blocking and vesicle depletion were combined to produce complete dopamine system failure, severe gastric lesions resulted, and BPC-157 provided the most effective healing.

Best healer

BPC-157 outperformed ranitidine, atropine, and other drugs for healing gastric damage from complete dopamine system failure

What the researchers found

Complete dopamine system failure (combined haloperidol + reserpine) produced severe gastric lesions. BPC-157 provided superior healing compared to ranitidine, atropine, and other agents while also reducing associated catalepsy.

Why it matters

This demonstrates that dopamine is essential for stomach health and that BPC-157 can heal damage even from the most extreme dopaminergic disruption, reinforcing its unique interaction with the dopamine system.

How the study worked

Animal study in rats. Complete dopamine system failure induced by combined haloperidol + reserpine. BPC-157 compared to multiple reference drugs for gastric lesion healing and behavioral (catalepsy) effects.

What this study cannot tell us

Extreme pharmacological model that may not represent clinical scenarios. The mechanism of BPC-157's dopamine interaction was not fully elucidated.

How to read the evidence

Preliminary animal evidence from a novel model demonstrating clear therapeutic superiority with behavioral validation.

When this study was published

Published in 2000. BPC-157's dopamine system interaction continues to be studied for its implications across multiple organ systems.

The bigger picture

The gut-brain-dopamine connection is deeper than assumed. Complete dopamine failure damages the stomach, and BPC-157's ability to heal this damage while also correcting behavioral effects suggests it acts as a dopamine system stabilizer.

Questions still open

  • Does BPC-157 protect the gut from dopamine depletion in Parkinson's disease?
  • What is BPC-157's exact mechanism of dopamine system interaction?
  • Could BPC-157 prevent GI side effects of antipsychotic medications?

Common questions

Why does dopamine affect the stomach?
Dopamine receptors in the stomach help protect the mucosal lining. When the entire dopamine system fails (as in this extreme model), the stomach loses this protection and develops severe ulcers.
How does BPC-157 help?
BPC-157 healed the stomach damage better than standard drugs AND reduced the behavioral effects of dopamine failure, suggesting it stabilizes the dopamine system rather than just treating symptoms.

Read the original research

Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157.

Journal of physiology, Paris, 94(2), 105-10

View on PubMed ↗

Citation

Sikiric, P; Separovic, J; Buljat, G; Anic, T; Stancic-Rokotov, D; Mikus, D; Duplancic, B; Marovic, A; Zoricic, I; Prkacin, I; Lovric-Bencic, M; Aralica, G; Ziger, T; Perovic, D; Jelovac, N; Dodig, G; Rotkvic, I; Mise, S; Seiwerth, S; Turkovic, B; Grabarevic, Z; Petek, M; Rucman, R. (2000). Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157.. Journal of physiology, Paris, 94(2), 105-10.